Back to top

Funding available for the Clinic and Laboratory Integration Program

The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing, and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.

To this end, the Cancer Research Institute is requesting letters of intent for its Clinic and Laboratory Integration Program (CLIP). CRI offers CLIP grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Program Update

In partnership with the Chordoma Foundation, CRI has secured designated funding that will provide for additional CLIP grants focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine. Proposals in this area are encouraged. Please be advised that the Chordoma Foundation has chordoma models and banked tumor samples that are available to the research community. For more information on this, email grants@cancerresearch.org.

  LOI Deadline:


 
November 1, 2019
Selected applicants will be invited to submit a full research proposal with a submission deadline of February 15, 2020.
 
  Funding:
 
$200,000 over two years
 
  Eligibility:
 
Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation.